ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 83 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,174,984 | -37.1% | 166,193 | +22.4% | 0.00% | -100.0% |
| Q1 2024 | $1,867,072 | +49.5% | 135,787 | 0.0% | 0.00% | – |
| Q4 2023 | $1,249,241 | +22.2% | 135,787 | -19.7% | 0.00% | – |
| Q3 2023 | $1,022,565 | -22.0% | 169,019 | 0.0% | 0.00% | – |
| Q2 2023 | $1,311,587 | +74.2% | 169,019 | +49.9% | 0.00% | – |
| Q1 2022 | $753,000 | -42.6% | 112,748 | +1.4% | 0.00% | – |
| Q4 2021 | $1,312,000 | -56.4% | 111,159 | -6.8% | 0.00% | -100.0% |
| Q3 2021 | $3,007,000 | +47.5% | 119,217 | +3.5% | 0.00% | 0.0% |
| Q2 2021 | $2,038,000 | +13.7% | 115,198 | +57.4% | 0.00% | 0.0% |
| Q1 2021 | $1,793,000 | -22.1% | 73,198 | +7.7% | 0.00% | 0.0% |
| Q4 2020 | $2,302,000 | +172.1% | 67,996 | +100.9% | 0.00% | – |
| Q3 2020 | $846,000 | -25.6% | 33,844 | +0.4% | 0.00% | – |
| Q2 2020 | $1,137,000 | – | 33,693 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $4,673,631 | 14.75% |
| Nextech Invest Ltd. | 4,285,714 | $33,257,141 | 11.30% |
| Column Group LLC | 3,568,181 | $27,689,085 | 10.75% |
| Prosight Management, LP | 5,522,936 | $42,857,984 | 6.42% |
| Invus Financial Advisors, LLC | 1,007,575 | $7,818,782 | 4.18% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,450,822 | $11,258,379 | 3.48% |
| VR Adviser, LLC | 2,142,856 | $16,628,563 | 2.66% |
| Euclidean Capital LLC | 747,550 | $5,800,988 | 1.49% |
| Frazier Life Sciences Management, L.P. | 2,142,855 | $16,628,555 | 0.99% |
| Monaco Asset Management SAM | 378,222 | $2,935,003 | 0.82% |